TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33873154

Group type: EXPERIMENTAL
Intervention: Ketogenic diet (KD)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Recovery-stress questionnaire for athletes
Number of subjects: 8
Study: 34233913

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of allogenic cardiosphere-derived cells (CDCs)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study: 32946280

Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV)
Number of subjects: 452
Study: 36207033

Group type: EXPERIMENTAL
Intervention: SMS-intervention to reduce incidence of unintended pregnancy
Number of subjects: 866

Group type: EXPERIMENTAL
Intervention: Not using a highly effective contraceptive
Number of subjects: 866

Group type: EXPERIMENTAL
Intervention: Having ever experienced intimate partner violence (IPV)
Number of subjects: 866

Group type: COMPARATOR
Intervention: Age, sex work duration, partner status, contraceptive use, and IPV experience
Number of subjects: 866
Study: 33836822

Group type: EXPERIMENTAL
Intervention: Age at menarche (AAM)
Number of subjects: 329345

Group type: EXPERIMENTAL
Intervention: Age at natural menopause (ANM)
Number of subjects: 329345

Group type: EXPERIMENTAL
Intervention: Age at first birth (AFB)
Number of subjects: 329345
Study: 32775452

Group type: EXPERIMENTAL
Intervention: Health Warning Labels (HWLs) on cigarette packs
Number of subjects: 240
Study: 33619948

Group type: EXPERIMENTAL
Intervention: Circuit Training Group (CTG)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Sets Training Group (STG)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 29
Study: 32909229

Group type: EXPERIMENTAL
Intervention: Current appointment reminders
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Strategies used by patients to optimize reminders
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Recommendations for enhancing appointment reminders
Number of subjects: 27
Study: 36116086

Group type: EXPERIMENTAL
Intervention: Written Exposure Therapy (WET)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control (no additional contact)
Number of subjects: 46
Study: 34371963

Group type: EXPERIMENTAL
Intervention: Hydrolyzed chicken collagen type II (HCII) supplement
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 33138363

Group type: EXPERIMENTAL
Intervention: MP2-based machine learning representation
Number of subjects: 140
Study: 34536265

Group type: EXPERIMENTAL
Intervention: Mineralocorticoid receptor antagonists (MRAs)
Number of subjects: 4397

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4397
Study: 34859634

Group type: EXPERIMENTAL
Intervention: Er:YAG laser combined with ethylenediamine tetra acetic acid (EDTA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 30
Study: 32114996

Group type: EXPERIMENTAL
Intervention: Angiotensin II added to standard of care (SOC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care (SOC) alone
Number of subjects: 0
Study: 32202619

Group type: EXPERIMENTAL
Intervention: Multimicronutrient group A (7 micronutrients at RDA)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Multimicronutrient group B (22 micronutrients at RDA)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Multimicronutrient group C (22 micronutrients at 3RDA)
Number of subjects: 190
Study: 35753964

Group type: EXPERIMENTAL
Intervention: Tailored over-the-counter medication safety intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 34945739

Group type: COMPARATOR
Intervention: Control (saline bolus and midazolam infusion [0.05 mg/kg loading, 20 µg/kg/h thereafter])
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: DMED (saline bolus and dexmedetomidine infusion [1 µg/kg loading, 0.4 µg/kg/h thereafter])
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: DEXA (dexamethasone [10 mg] bolus and midazolam infusion)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: DMED‐DEXA (dexmedetomidine infusion and dexamethasone bolus)
Number of subjects: 120
Study: 32036754

Group type: EXPERIMENTAL
Intervention: Quality Improvement Project (QIP) interventions including improving IT access, education event, and reminder emails for clinicians.
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Quality Improvement Project (QIP) interventions
Number of subjects: 30
Study: 32061297

Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 34964676

Group type: EXPERIMENTAL
Intervention: Electrophysiology-based software-guided cochlear implant fitting method (5-electrode method)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Electrophysiology-based software-guided cochlear implant fitting method (all 22 electrodes)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard clinical software fitting method
Number of subjects: 48
Study: 33559436

Group type: EXPERIMENTAL
Intervention: Acupuncture-moxibustion
Number of subjects: 66

Group type: COMPARATOR
Intervention: Sham-acupuncture and sham-moxibustion
Number of subjects: 66
Study: 32498266

Group type: EXPERIMENTAL
Intervention: Frequent dairy consumption (FR)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Dairy consumption (general)
Number of subjects: 45
Study: 36102392

Group type: EXPERIMENTAL
Intervention: Convalescent plasma (COPLA) with standard medical care
Number of subjects: 29

Group type: COMPARATOR
Intervention: Fresh frozen plasma (FFP) with standard medical care
Number of subjects: 29
Study: 33713361

Group type: EXPERIMENTAL
Intervention: Partial removable dental prosthesis (PRDP)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Shortened dental arch (SDA)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Both PRDP and SDA groups
Number of subjects: 152
Study: 32162287

Group type: EXPERIMENTAL
Intervention: Fork-tip fine-needle biopsy (FNB)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Fine-needle aspiration (FNA)
Number of subjects: 108
Study: 35798475

Group type: EXPERIMENTAL
Intervention: Ultrathin, biodegradable-polymer sirolimus-eluting stent (BP-SES)
Number of subjects: 1440

Group type: COMPARATOR
Intervention: Thin, durable-polymer everolimus-eluting stent (DP-EES)
Number of subjects: 1440
Study: 33387486

Group type: EXPERIMENTAL
Intervention: CLEAR (levofloxacin, ethambutol, azithromycin, and rifabutin)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: CLEAR
Number of subjects: 97
Study: 35393614

Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg daily
Number of subjects: 15427

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15427
Study: 32517693

Group type: EXPERIMENTAL
Intervention: erenumab 70 mg
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: erenumab 140 mg
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: erenumab 70 mg and 140 mg
Number of subjects: 70
Study: 34229690

Group type: EXPERIMENTAL
Intervention: Lifestyle and body weight recommendations adherence
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Behavior Change Techniques
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Qualitative research methods (semi-structured interviews, focus groups)
Number of subjects: 1000
Study: 34327583

Group type: EXPERIMENTAL
Intervention: PI-QUAL score assessment by two radiologists
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: PI-QUAL score assessment clustered into three groups (PI-QUAL 1-2 vs PI-QUAL 3 vs PI-QUAL 4-5)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: T2-weighted imaging
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Dynamic contrast-enhanced sequences
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Diffusion-weighted imaging
Number of subjects: 103
Study: 32162721

Group type: EXPERIMENTAL
Intervention: Tildrakizumab 100 mg Q12W
Number of subjects: 2117

Group type: EXPERIMENTAL
Intervention: Tildrakizumab 200 mg Q12W
Number of subjects: 2117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2117
Study: 36078691

Group type: EXPERIMENTAL
Intervention: Diacutaneous Fibrolysis (DF)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 44
Study: 33060493

Group type: COMPARATOR
Intervention: 0.2% ropivacaine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.375% ropivacaine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine
Number of subjects: 30
Study: 32667383

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo taping
Number of subjects: 60

Group type: COMPARATOR
Intervention: No taping (control)
Number of subjects: 60
Study: 35113228

Group type: EXPERIMENTAL
Intervention: Trocar-less trans-vaginal mesh (TTMs)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Laparoscopic pelvic organ prolapse surgery (POPs)
Number of subjects: 59
Study: 33252480

Group type: EXPERIMENTAL
Intervention: rosuvastatin 20 mg daily (10 mg if co-administered with ritonavir/cobicistat)
Number of subjects: 88

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: rosuvastatin
Number of subjects: 88
Study: 32236822

Group type: EXPERIMENTAL
Intervention: Induction (mitoxantrone or cyclophosphamide)
Number of subjects: 813

Group type: COMPARATOR
Intervention: Escalation (interferon beta)
Number of subjects: 813
Study: 35461831

Group type: EXPERIMENTAL
Intervention: Aflibercept or bevacizumab treatment
Number of subjects: 330
Study: 33812296

Group type: EXPERIMENTAL
Intervention: Family participatory dignity therapy (2-3 interviews lasting 45-60 minutes each)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Family participatory dignity therapy
Number of subjects: 68

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 68
Study: 35031969

Group type: EXPERIMENTAL
Intervention: Bifidobacterium lactis CCT 7858 at 9 × 10^10 CFU concentration
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Bifidobacterium lactis CCT 7858
Number of subjects: 104
Study: 33626296

Group type: EXPERIMENTAL
Intervention: Discussion of vaccinomics
Number of subjects: 0
Study: 32716206

Group type: EXPERIMENTAL
Intervention: Suxiao Jiuxin Pill (SJP)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 34879916

Group type: EXPERIMENTAL
Intervention: Fatigue strength exercise
Number of subjects: 10
Study: 32349716

Group type: EXPERIMENTAL
Intervention: Risk-avoidance NCCs located on the left side of the package
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Benefit-seeking NCCs located on the right side of the package
Number of subjects: 365
Study: 33722583

Group type: EXPERIMENTAL
Intervention: TAK-101
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 33238677

Group type: EXPERIMENTAL
Intervention: Group A (0.5 ml/kg)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Group B (0.6 ml/kg)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Group C (0.8 ml/kg, flow rate 5 ml/s)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Flow rates of contrast agents
Number of subjects: 270

Group type: COMPARATOR
Intervention: Amount of contrast agent
Number of subjects: 270

Group type: COMPARATOR
Intervention: Effective dose (ED)
Number of subjects: 270
Study: 36277012

Group type: EXPERIMENTAL
Intervention: Nifedipine, labetalol, and magnesium sulfate
Number of subjects: 100

Group type: COMPARATOR
Intervention: Nifedipine combined with magnesium sulfate
Number of subjects: 100
Study: 33189876

Group type: EXPERIMENTAL
Intervention: Coping With Stress (CWS), a cognitive-behavioral program
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy-Adolescent Skills Training (IPT-AST), an interpersonal program
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Matched adolescents
Number of subjects: 204
Study: 32147070

Group type: EXPERIMENTAL
Intervention: Licorice pastille
Number of subjects: 70
Study: 34839364

Group type: EXPERIMENTAL
Intervention: KET 0.5 (0.5 mg/kg)
Number of subjects: 33

Group type: COMPARATOR
Intervention: MID (midazolam 0.03 mg/kg)
Number of subjects: 33
Study: 34930986

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Dapagliflozin combined with Metformin
Number of subjects: 248
Study: 33502265

Group type: EXPERIMENTAL
Intervention: Brief Behavioral Treatment for Insomnia (BBTI)
Number of subjects: 46
Study: 32146042

Group type: EXPERIMENTAL
Intervention: Radial AP bowing assessment
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Radial lateral bowing assessment
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Ulnar AP bowing assessment
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Ulnar lateral bowing assessment
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Side-to-side differences assessment
Number of subjects: 211
Study: 36097559

Group type: EXPERIMENTAL
Intervention: Sotagliflozin 200 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Sotagliflozin 400 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 33666026

Group type: EXPERIMENTAL
Intervention: Lever positioning manipulation
Number of subjects: 67

Group type: COMPARATOR
Intervention: Lumbar slanting manipulation
Number of subjects: 67
Study: 32020660

Group type: EXPERIMENTAL
Intervention: Nonjudgment mindfulness
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: General mindfulness
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Nothing
Number of subjects: 120
Study: 34657640

Group type: EXPERIMENTAL
Intervention: L-arabinose (7.5 g) co-ingested with sucrose (50 g)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (sucrose 50 g without L-arabinose)
Number of subjects: 12
Study: 33811444

Group type: EXPERIMENTAL
Intervention: CPCs alone
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: MSCs alone
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: MSCs + CPCs
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study: 32729334

Group type: EXPERIMENTAL
Intervention: Platycodon grandiflorum (PG)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125

Group type: COMPARATOR
Intervention: Platycodon grandiflorum (PG) and Placebo
Number of subjects: 125
Study: 35240074

Group type: EXPERIMENTAL
Intervention: Avatrombopag 60 mg once daily for 5 days before and after chemotherapy
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Avatrombopag (per protocol)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo (per protocol)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Avatrombopag
Number of subjects: 122
Study: 34186380

Group type: EXPERIMENTAL
Intervention: Green tea mouthwash (100 ml for 60 seconds after brushing)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Tap water mouthwash (100 ml for 60 seconds after brushing)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Green tea mouthwash
Number of subjects: 63

Group type: COMPARATOR
Intervention: Tap water mouthwash
Number of subjects: 63
Study: 34348743

Group type: EXPERIMENTAL
Intervention: Complex intervention comprising academic detailing, enrolment in a community of practice, and resources
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Complex intervention
Number of subjects: 86
Study: 35987671

Group type: EXPERIMENTAL
Intervention: SMILe‐ICM
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 80
Study: 33523511

Group type: EXPERIMENTAL
Intervention: Single-arm trials using historical controls
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard randomized controlled clinical trials
Number of subjects: 0
Study: 32313988

Group type: COMPARATOR
Intervention: No DVT
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: DVT
Number of subjects: 251
Study: 36222372

Group type: EXPERIMENTAL
Intervention: Danofloxacin 5 mg/kg body weight, administered orally (PO)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Danofloxacin 5 mg/kg body weight, administered intravenously (IV)
Number of subjects: 18
Study: 33753443

Group type: EXPERIMENTAL
Intervention: Hopewell Hospitalist video game intervention
Number of subjects: 30
Study: 32791711

Group type: EXPERIMENTAL
Intervention: rMS at HT7 acupoint
Number of subjects: 45

Group type: COMPARATOR
Intervention: rTMS at r-DLPFC
Number of subjects: 45

Group type: COMPARATOR
Intervention: No treatment (waiting treatment)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: All groups (rMS, rTMS, No treatment)
Number of subjects: 45
Study: 35419607

Group type: EXPERIMENTAL
Intervention: Nivolumab (NIVO) + Radiotherapy (RT)
Number of subjects: 560

Group type: COMPARATOR
Intervention: Temozolomide (TMZ) + Radiotherapy (RT)
Number of subjects: 560
Study: 33620901

Group type: COMPARATOR
Intervention: Phone counseling
Number of subjects: 84

Group type: COMPARATOR
Intervention: Office counseling
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 84
Study: 32069352

Group type: EXPERIMENTAL
Intervention: Improved nutrition in early life
Number of subjects: 1112

Group type: COMPARATOR
Intervention: Unexposed women
Number of subjects: 1112

Group type: COMPARATOR
Intervention: Unexposed men
Number of subjects: 1112
Study: 36454876

Group type: EXPERIMENTAL
Intervention: Isokinetic strength training (IST)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Thera-Band resistance training (TBT)
Number of subjects: 52
Study: 34237132

Group type: EXPERIMENTAL
Intervention: Anterior quadratus lumborum block with multimodal analgesia (30 ml bupivacaine 0.5% with 2 mg preservative-free dexamethasone)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Multimodal analgesia alone
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Both groups (anterior quadratus lumborum block and multimodal analgesia alone)
Number of subjects: 96
Study: 34003054

Group type: EXPERIMENTAL
Intervention: Five clinical scoring systems (adult appendicitis, appendicitis inflammatory response, modified Alvarado, Broek, and Christian scores)
Number of subjects: 2888
Study: 36216650

Group type: EXPERIMENTAL
Intervention: High-dose quadrivalent influenza vaccine (QIV-HD)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Standard-dose quadrivalent influenza vaccine (QIV-SD)
Number of subjects: 165
Study: 34867500

Group type: EXPERIMENTAL
Intervention: Laypeople-delivered community psychiatric rehabilitation
Number of subjects: 94
Study: 34543873

Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 7

Group type: COMPARATOR
Intervention: False acupuncture/sham
Number of subjects: 7
Study: 32919210

Group type: EXPERIMENTAL
Intervention: PTSS (Post-Traumatic Stress Symptoms)
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: PTSS in girls
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: PTSS in boys
Number of subjects: 291

Group type: COMPARATOR
Intervention: Trauma exposure
Number of subjects: 291
Study: 36098037

Group type: EXPERIMENTAL
Intervention: Carboplatin plus nab-paclitaxel
Number of subjects: 196

Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 196
Study: 32871454

Group type: EXPERIMENTAL
Intervention: Probiotic (Bifidobacterium breve M16-V)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 35644959

Group type: EXPERIMENTAL
Intervention: HFNO-assisted early extubation (Group H)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional extubation (Group C)
Number of subjects: 40
Study: 33230964

Group type: EXPERIMENTAL
Intervention: Large Changes (produce buffer by losing 5-10 pounds initially)
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Small Changes (daily small changes in intake and activity)
Number of subjects: 599

Group type: COMPARATOR
Intervention: Control
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: All interventions combined
Number of subjects: 599
Study: 35832798

Group type: EXPERIMENTAL
Intervention: Rhomboid Intercostal Block (RIB)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block (ESP)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Serratus Plane Block (SAB)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: RIB
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: ESP
Number of subjects: 90

Group type: COMPARATOR
Intervention: SAB
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: RIB and ESP
Number of subjects: 90

Group type: COMPARATOR
Intervention: RIB, ESP, and SAB
Number of subjects: 90
Study: 33857018

Group type: EXPERIMENTAL
Intervention: Milk PL-enriched cream cheese (0, 3, or 5 g of milk PL)
Number of subjects: 58
Study: 34126506

Group type: EXPERIMENTAL
Intervention: NaOCl-21 °C
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: NaOCl-60 °C
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Saline-80 °C
Number of subjects: 92

Group type: COMPARATOR
Intervention: Saline-21 °C
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: NaOCl-80 °C
Number of subjects: 92
Study: 35411169

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet (MD) with good adherence over 12 weeks (KIDMED 8-point score)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual diet (KIDMED score ≤7 points)
Number of subjects: 100
Study: 34578969

Group type: EXPERIMENTAL
Intervention: Korean Red Ginseng (KRG)
Number of subjects: 63
Study: 33216975

Group type: EXPERIMENTAL
Intervention: Stem cell transplantation (SCT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard-care (chronic transfusion for 1-year minimum)
Number of subjects: 60
Study: 35723240

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 1000
Study: 33545784

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided indwelling cannula needle
Number of subjects: 61

Group type: COMPARATOR
Intervention: Blind indwelling cannula needle
Number of subjects: 61
Study: 33120774

Group type: EXPERIMENTAL
Intervention: Triple injection (TI group, n=34)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Single injection (SI group, n=34)
Number of subjects: 68
Study: 35442220

Group type: EXPERIMENTAL
Intervention: Specific Carbohydrate Diet (SCD)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Modified Specific Carbohydrate Diet (MSCD)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Usual Diet (UD)
Number of subjects: 54